The Addario Lung Cancer Medical Institute (ALCMI, voiced as “Alchemy”), founded in 2008 as a 501c(3) non-profit organization, is a patient-centric, international research consortium driving research otherwise not feasible. ALCMI overcomes barriers to collaboration via a world-class team of investigators from more than 25 institutions in the United States, France, Italy, Spain and United Kingdom, supported by dedicated research infrastructures such as centralized tissue banks and data systems.
ALCMI directly facilitates research by combining scientific expertise found at leading academic institutions with patient access through our network of community cancer centers – accelerating novel research advancements to lung cancer patients in partnership with diagnostics and bio-pharmaceutical companies.
